ARS Pharmaceuticals, Inc. (SPRY)

ARS Pharmaceuticals Revenue

In the year 2023, ARS Pharmaceuticals had annual revenue of $30.00K, a decrease of -97.72%.

• Revenue (ttm): $30.00K
• Revenue Growth: -97.72%
• P/S Ratio: 29,304.32
• Revenue / Employee: $1,250
• Employees: 24
• Market Cap: 880.09M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	30.00K	-1.29M	-97.72%
Dec 31, 2022	1.32M	-4.19M	-76.10%
Dec 31, 2021	5.51M	-	-
Dec 31, 2020	0	-	-
Dec 31, 2019	0	-	-
Dec 31, 2018	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.